{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T22:18:23Z","timestamp":1786832303943,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jhepr.2023.100671","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T12:22:57Z","timestamp":1674044577000},"page":"100671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3240-5152","authenticated-orcid":false,"given":"Simon Johannes","family":"Gairing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Danneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-8003","authenticated-orcid":false,"given":"Leonard","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Schleicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Quack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinah","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-0621","authenticated-orcid":false,"given":"Peter Robert","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn Markus","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus-Alexander","family":"W\u00f6rns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Luessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Uwe","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-9663","authenticated-orcid":false,"given":"Christian","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100671_bib1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100671_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100671_bib3","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.cgh.2015.06.039","article-title":"Covert and overt hepatic encephalopathy: diagnosis and management","volume":"13","author":"Patidar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100671_bib4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100671_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/apt.14824","article-title":"Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients","volume":"48","author":"Labenz","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100671_bib6","first-page":"49","article-title":"Management der hepatischen Enzephalopathie in Deutschland: eine Umfrage unter Gastroenterologen und Allgemeinmedizinern","volume":"58","author":"Labenz","year":"2020","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100671_bib7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/hep4.1883","article-title":"Evaluation of IL-6 for stepwise diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis","volume":"6","author":"Gairing","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100671_bib8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jhep.2022.07.014","article-title":"Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis","volume":"77","author":"Tranah","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100671_bib9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11011-020-00549-8","article-title":"Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema","volume":"35","author":"Sepehrinezhad","year":"2020","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhepr.2023.100671_bib10","article-title":"Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death","volume":"4","author":"Angelova","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100671_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jhepr.2023.100671_bib12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","journal-title":"Prog Neurobiol"},{"issue":"Suppl. 1","key":"10.1016\/j.jhepr.2023.100671_bib13","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.jceh.2014.02.004","article-title":"Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure","volume":"5","author":"Butterworth","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2023.100671_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33158-8","article-title":"Serum GFAP as a biomarker for disease severity in multiple sclerosis","volume":"8","author":"Abdelhak","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100671_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/lt.25032","article-title":"Assessment of the spectrum of hepatic encephalopathy: a multicenter study","volume":"24","author":"Reuter","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2023.100671_bib25","doi-asserted-by":"crossref","unstructured":"Weissenborn K, Ennen JC, Schomerus H, R\u00fcckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001 May;34(5):768-73. doi:10.1016\/s0168-8278(01)00026-5. PMID: 11434627.","DOI":"10.1016\/S0168-8278(01)00026-5"},{"key":"10.1016\/j.jhepr.2023.100671_bib16","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000419","article-title":"Association between serum levels of neurofilament light chains and minimal hepatic encephalopathy in patients with liver cirrhosis","volume":"12","author":"Labenz","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100671_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1474-4422(19)30282-0","article-title":"Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study","volume":"18","author":"Yue","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jhepr.2023.100671_bib18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00134-021-06481-4","article-title":"Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest","volume":"47","author":"Moseby-Knappe","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhepr.2023.100671_bib19","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/alz.12806","article-title":"Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: the effect of sample stability","volume":"18","author":"Simr\u00e9n","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jhepr.2023.100671_bib20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/00207450802333672","article-title":"Chronic ethanol-induced glial fibrillary acidic protein (GFAP) immunoreactivity: an immunocytochemical observation in various regions of adult rat brain","volume":"119","author":"Dal\u00e7ik","year":"2009","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jhepr.2023.100671_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mus.21323","article-title":"Glial fibrillary acidic protein as a marker of axonal damage in chronic neuropathies","volume":"40","author":"Notturno","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jhepr.2023.100671_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12975-010-0040-6","article-title":"Astroglial proteins as diagnostic\u00a0markers of acute intracerebral hemorrhage-pathophysiological\u00a0background and clinical findings","volume":"1","author":"Brunkhorst","year":"2010","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jhepr.2023.100671_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/gut.2003.012625","article-title":"Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia","volume":"53","author":"von Boyen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100671_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0197-4580(93)90100-P","article-title":"GFAP mRNA increases\u00a0with age in rat and human brain","volume":"14","author":"Nichols","year":"1993","journal-title":"Neurobiol Aging"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:30:57Z","timestamp":1762900257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2589555923000022"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100671","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100671"}}